Where We Are Headed - New Outlook on Forest Laboratories, Inc.

Where We Are Headed - New Outlook on Forest Laboratories, Inc. and
Teva Pharmaceutical Industries Limited 
JAKARTA, INDONESIA -- (Marketwire) -- 09/26/12 --  Moments ago,
NationalTradersAssociation.org introduced new coverage of Forest
Laboratories, Inc. (NYSE: FRX) and Teva Pharmaceutical Industries
Limited (NYSE: TEVA). Full outlook, analysis and consensus opinion is
available to readers via the links
The consistent delivery of accurate analyses relies solely on two
factors, namely: market awareness and industry insight. Recent market
drivers include August's existing home sales increasing more than
expected within the U.S., a surprise slip in U.S. initial jobless
claims in the week ending September 15, 2012 and the spark of U.S.
housing starts over the last month. When it comes to discovering the
right edge at the right time, all these factors play into effect. For
a deeper understanding of the mechanics behind these events and how
it can affect your portfolio, please refer to our email newsletter
delivered to your inbox. 
National Traders Association is releasing new coverage on Forest
Laboratories, Inc. for its current position within the consumer
durables sector. Forest Laboratories, Inc. (Forest) develops,
manufactures and sells branded forms of ethical drug products, most
of which requires a physician's prescription. The Company also
focuses on the development and introduction of new products,
including products developed in collaboration with licensing
partners. A copy of this report featuring Forest Laboratories, Inc.
(NYSE: FRX) is available at:
National Traders Association has released research on Teva
Pharmaceutical Industries Limited for its changing role within the
consumer durables sector. Teva Pharmaceutical Industries Ltd (Teva)
is a global pharmaceutical and drug company. It develops, produces
and markets generic drugs in all treatment categories. The Company
has a pharmaceutical business, whose principal products include
Copaxone and Azilect. To access the full research report on Teva
Pharmaceutical Industries Limited (NYSE: TEVA) we welcome investors
to visit: www.NationalTradersAssociation.org/r/gov/42ce_TEVA. 
Consider National Traders Association
 Tired of hearing about the
latest, greatest trade opportunity... only to realize that the ship
has long sailed? You need a strong, informative community in your
arsenal. Join the group that has been consistently identifying
momentous situations as they develop -- long before they become the
next top news on major financial networks. 
Demi Lapierre
Press spacebar to pause and continue. Press esc to stop.